TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
EYPT

Eyepoint Pharmaceuticals Inc

Healthcare · Biotechnology

3.90$ -3.5% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Eyepoint Pharmaceuticals Inc (EYPT): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/04/2026.

Next report 11/04/2026
Last report 08/05/2026
Earnings surprise by quarter (%)
Q3 23 · 35.3 % 23 Q4 23 · 32.7 % 23 Q1 24 · -31.0 % 24 Q2 24 · -13.7 % 24 Q3 24 · 0.0 % 24 Q4 24 · -34.3 % 24 Q1 25 · 5.8 % 25 Q2 25 · -6.3 % 25 Q3 25 · -10.4 % 25 Q4 25 · -8.3 % 25 Q1 26 · -22.2 % 26 Q2 26 · -18.5 % 26

EPS estimate beaten

Full history 31 of 67 quarters (46%)
Last 16 quarters 5 of 16 quarters (31%)

Earnings Call Transcripts

Search all transcripts →

  • 05/06/2026 Earnings Call Q1 2026 Open →
  • 03/04/2026 Earnings Call Q4 2025 Open →
  • 11/05/2025 Earnings Call Q3 2025 Open →
  • 08/06/2025 Earnings Call Q2 2025 Open →
  • 05/07/2025 Earnings Call Q1 2025 Open →
  • 03/05/2025 Earnings Call Q4 2024 Open →

News on This Stock

  • 09/10/2026 EyePoint, Inc. (EYPT): Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/17/2026 EyePoint, Inc. (EYPT): Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/05/2026 EyePoint, Inc. (EYPT): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/30/2026 EyePoint, Inc. (EYPT): Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 07/17/2026 EyePoint, Inc. (EYPT): Entry into a Material Definitive Agreement; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?